CSIR launches India’s first ayurvedic anti-diabetic drug named BGR-34

The Council for Scientific and Industrial Research (CSIR) has launched the country’s first anti-diabetic ayurvedic drug named BGR-34 for type two Diabetes mellitus.

BGR-34 stands for Blood Glucost Regulator and offers effective, safe, patient-friendly solution for managing type two Diabetes.

About BGR-34

  • The drug has been jointly developed by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP) and CSIR institutes based in Lucknow.
  • It contains 34 identified active phyto-constitutes from herbal resources and works by controlling blood sugar and limiting the harmful effects of other modern drugs.
  • For the purpose of quality commercial production and extended distribution of this drug, CSIR has transferred the rights and technical details to AIMIL Pharmaceuticals (I) Ltds.

Advertisement

Categories: Science and Technology Current Affairs - 2017

Tags:

advertisement

Comments